亚洲精品国产成人一区二区_欧美性xxxxx极品娇小_国产欧美久久一区二区三区_日日麻批免费40分钟无码
Home
About
Capabilities
R&D
Investors
News
Careers
中文
Home
About
Capabilities
R & D
Investors
News
Careers
Press Release
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
Sep 06, 2021
The Taizhou Antibody Industrial Base of Mabwell Successfully Passed the EU QP Audit
?
Aug 26, 2021
Mabwell and FEGO Reached Cooperation Agreement on the Commercialization of a Proposed Biosimilar of Adalimumab
?
Aug 20, 2021
Mabwell Receives IND Clearance from FDA for Initiating Clinical Trials for its Anti-CD47/PD-L1 Bispecific Antibody
?
Aug 10, 2021
NMPA Accepted IND Application of China's First Anti-Nectin-4 ADC Drug
?
Aug 08, 2021
Give a Better Play to Hardcore Strengths of Harnessing Science and Technology to Combat COVID-19 Epidemic - Zhang Quan, Director of Science and Technology Commission of Shanghai Municipality, made an inspection to Mabwell
?
Aug 02, 2021
Mabwell Was Included in the "List of New and Innovative Chinese Pharmaceutical Forces 2021"
?
Jul 21, 2021
Mabwell's Anti-CD47/PD-L1 Bispecific Antibody 6MW3211 Receives IND Approval in China
?
Jul 20, 2021
Activity Review | Harmony and Advancement, Deep Cultivation and Empowerment - Mabwell The 4th Science & Technology Conference
?
Jul 09, 2021
Mabwell and Fudan University Shanghai Cancer Center Announce Strategic Cooperation
?
Jul 08, 2021
Mabwell was included into the 2021 Chinese Pharmaceutical Talent Brand
?
Previous
1
2
3
Next
主站蜘蛛池模板:
新疆
|
昆明市
|
柳江县
|
新巴尔虎左旗
|
易门县
|
本溪
|
台湾省
|
柳河县
|
柘城县
|
福安市
|
甘孜
|
凤庆县
|
壶关县
|
微博
|
百色市
|
新建县
|
平陆县
|
百色市
|
酉阳
|
红安县
|
郑州市
|
历史
|
宁南县
|
老河口市
|
鲁甸县
|
凤山市
|
鲁山县
|
黄冈市
|
丘北县
|
文化
|
合川市
|
特克斯县
|
芦溪县
|
盐津县
|
贵南县
|
凌源市
|
都昌县
|
湖口县
|
和林格尔县
|
西乌珠穆沁旗
|
慈溪市
|